Model-based drug development employs mathematical and statistical models to describe disease progression, PK, and PD; to improve study design; and to better enable decision making. 19 It works as a ...

In January, the U.S. Food and Drug Administration (FDA) issued its first guidance on the use of artificial intelligence (AI) models in ...

There is growing enthusiasm about China’s potential to speed up drug development with AI. And companies outside the country ...

A new generative AI model rapidly generates diverse antimicrobial peptide structures for screening against ...

A collaborative research team led by Professor Jinah Jang from the Department of Mechanical Engineering and the Department of ...

A 3D model has been developed that accurately replicates the complex structures of cerebral blood vessels, enabling ...